大型B细胞淋巴瘤在CD19导向的CAR T细胞治疗后复发的治疗选择
Samantha El Warrak1, Mohamed A Kharfan-Dabaja2, Madiha Iqbal2
1Department of Internal Medicine, University of Connecticut, Farmington, CT, USA.
Bone marrow transplantation
|December 15, 2023
概括
化学抗原受体T细胞疗法 (CAR T) 为大型B细胞淋巴瘤 (LBCL) 提供了新的希望,但对没有反应的患者仍然存在挑战. 本综述探讨了在LBCL中CART失败后优化结果的策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 化学抗原受体T细胞疗法 (CAR T) 已经改变了大型B细胞淋巴瘤 (LBCL) 治疗.
- 显著的一小部分LBCL患者无法实现对CAR T治疗的持久反应.
研究的目的:
- 审查和分析治疗后复发或耐药LBCL患者的管理策略.
- 评估各种治疗方式在CAR T后环境中的疗效.
主要方法:
- 对LBCL后CART衰竭治疗方法的现有数据的文献综述.
- 对单克隆抗体,抗体与药物合物,双特异性抗体和全原造血细胞移植研究的分析.
主要成果:
- 针对CD19的疗法在CAR T后的环境中显示出有限的疗效.
- 双特异性抗体提供了一个替代方案,但缺乏CAR T后的长期随访数据.
- 异质造血细胞移植显示出有效性,但前提是在手术前实现完全缓解.
结论:
- 在CART衰竭后治疗LBCL是一个重大的治疗挑战.
- 需要采用多方面的治疗方法来优化这些患者的治疗结果.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

